Our researches are aimed at developing new technologies for studying the brain and for the diagnosis and treatment of diseases related to the nervous system. Such as new methods of processing and fusion of neuroimaging, methods to study brain connectivity, characterize the maturation of basic psychological and neural processes in school age children and new methods to characterize auditory and visual sensory processes.
We work on several projects of social impact related to disabilities caused by neural dysfunction, neurodevelopmental problems and aging, covering major populations groups, closing R & D cycle to ensure the creation of new products.
The Department of Neurochemistry, consists of three groups: Neurochemistry, Molecular Neurobiology and Experimental Neurobiology and has as its central objective the search for biological and chemical markers for the diagnosis and treatment of Alzheimer's disease. It also has three patents in several countries.
- Development of an induced-Alzheimer-type animal model, in order to be able to assess the compounds in vivo through behavioral and histological tests.
- Biomarkers joint search to identify traces of pathophysiological diseases